P09.25 Identifying the correct patient (pt) population for ABT414: biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM)

Aim: Aberrant EGFR signaling plays a vital role in GBM oncogenesis. ABT414 comprises an EGFR targeted antibody conjugated to the toxic agent monomethylauristatin F. An open label, 3 arm, phase I study (NCT01800695) is underway to evaluate 3 different ABT414 regimens in GBM. To understand the populat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Lassman, A., Gan, H., Robert-Rapp, L., Ansell, P., Merrell, R., Kumthekar, P., Gomez, E., Holen, K., Reardon, D., van den Bent, M.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
POSTER PRESENTATIONS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.281
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki